ArticleThe Journal of clinical and aesthetic dermatology2025

Impact of Oral DFD-29, a Low-Dose Formulation of Minocycline, on Quality of Life in Patients with Rosacea: Results of Two Phase 3 Randomized Controlled Trials.

Linda Stein Gold et al.PubMed ↗Full text ↗

No numbers read from the abstract.